D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kosmos Energy
KOS
$1.45B
| $3.42M | 0.01% |
430,162
-206,378
| -32% | -$1.43M |
|
|
SCLN
1627
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $3.42M | 0.01% |
305,279
+19,132
| +7% | +$211K |
|
1628
Banner Corp
BANR
$2.39B
| $3.42M | 0.01% |
55,723
-7,861
| -12% | -$445K |
|
1629
Iridium Communications
IRDM
$4.87B
| $3.42M | 0.01% |
331,517
+148,601
| +81% | +$1.54M |
|
|
DF
1630
DELISTED
Dean Foods Company
DF
| $3.41M | 0.01% |
313,520
+92,207
| +42% | +$1.19M |
|
1631
Medifast
MED
$110M
| $3.41M | 0.01% |
57,369
+4,656
| +9% | +$232K |
|
|
TTM
1632
DELISTED
Tata Motors Limited
TTM
| $3.41M | 0.01% |
+108,903
| New | +$3.5M |
|
1633
FirstEnergy
FE
$28.5B
| $3.4M | 0.01% |
110,322
-1,185,329
| -91% | -$37.3M |
|
1634
Omega Healthcare
OHI
$15.3B
| $3.4M | 0.01% |
106,426
-117,297
| -52% | -$3.76M |
|
1635
Foster
FSTR
$443M
| $3.39M | 0.01% |
148,801
+14,646
| +11% | +$286K |
|
|
SBNY
1636
PUT
DELISTED
Signature Bank
SBNY
| $3.38M | 0.01% |
+26,400
| New | +$3.47M |
|
|
DYNC
1637
DELISTED
Vistra Energy Corp.
DYNC
| $3.38M | 0.01% |
+50,000
| New | +$3.22M |
|
1638
Ionis Pharmaceuticals
IONS
$9.25B
| $3.38M | 0.01% |
66,568
+12,704
| +24% | +$665K |
|
1639
Williams-Sonoma
WSM
$27.6B
| $3.37M | 0.01% |
135,282
-16,924
| -11% | -$393K |
|
1640
Blackstone Mortgage Trust
BXMT
$2.8B
| $3.36M | 0.01% |
108,416
+46,820
| +76% | +$1.46M |
|
1641
Watts Water Technologies
WTS
$11.5B
| $3.35M | 0.01% |
48,467
-2,135
| -4% | -$137K |
|
|
CATM
1642
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $3.35M | 0.01% |
+145,626
| New | +$4.14M |
|
1643
Equinor
EQNR
$91.4B
| $3.35M | 0.01% |
166,727
+106,472
| +177% | +$1.97M |
|
|
KBAL
1644
DELISTED
Kimball International
KBAL
| $3.34M | 0.01% |
168,946
-6,098
| -3% | -$104K |
|
1645
PUT
Allegiant Air
ALGT
$2.66B
| $3.33M | 0.01% |
+25,300
| New | +$3.26M |
|
1646
Varex Imaging
VREX
$463M
| $3.33M | 0.01% |
98,470
+28,063
| +40% | +$878K |
|
1647
MarketAxess Holdings
MKTX
$4.19B
| $3.33M | 0.01% |
18,049
+1,088
| +6% | +$208K |
|
1648
Koppers
KOP
$954M
| $3.32M | 0.01% |
71,909
-6,266
| -8% | -$244K |
|
|
CS
1649
DELISTED
Credit Suisse Group
CS
| $3.31M | 0.01% |
+209,176
| New | +$3.18M |
|
|
EGL
1650
DELISTED
Engility Holdings, Inc.
EGL
| $3.3M | 0.01% |
95,193
-9,659
| -9% | -$294K |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.